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Abstract 
We report a highly diastereoselective approach for the synthesis of the pentacyclic indole core of the 
manadomanzamine alkaloid skeleton, with complete control over the relative and absolute stereochemistries at 
the three contiguous stereocentres at ring positions 1, 10, and 24, from a readily available chiral template.  
 
In 2003 Hamann and co-workers reported the isolation of two novel marine alkaloids, 
manadomanzamine A and B, from the Indonesian sponge Acanthostrongylophora sp.1 These 
compounds were found to exhibit strong activity against myobacterium tuberculosis (Mtb) with MIC 
values of 1.9 and 1.5 μg/mL respectively. In addition these alkaloids show activities against HIV-1 and 
AIDS opportunistic infections. The recent increasing occurrence and threat of tuberculosis has renewed 
interest in the development of anti-tuberculosis agents, since the W.H.O. estimates that currently one-
third of the worlds population is infected with TB, with 3.1 million deaths occurring per annum. 
Further, such a lead compound with activity against both HIV-1 and AIDS opportunistic infections is 
of significant value. A plausible biosynthetic pathway to the manadomanzamines has been proposed 
from the more common manzamine alkaloids.1 To date no total synthesis of the manadomanzamines 
has been reported, and indeed a general and stereoselective approach to simpler core analogues, 
including 1, a dodecahydrobenz[a]indolo[3,2-h]quinolizine, is still lacking. This pentacyclic ring 
system, sometimes referred to as an “inside yohimbane,” has previously been prepared in racemic 
fashion by Morrison and co-workers.,2 and has been observed as a by-product in approaches to racemic 
yohimbine and reserpine by Martin.3 Our research group, and others, have had considerable success in 
recent years in the development of asymmetric routes to several important heterocyclic templates, 
based around the development of highly diastereoselective N-acyliminium cyclization strategies.4 Our 
own recent applications of this methodology in natural product synthesis have included targets from the 
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erythrina group of alkaloids4f,i and several indole alkaloids.4a,d,e,g In this communication we report a 
highly diastereoselective construction of the manadomanzamine core, 1, with complete stereocontrol 
control over the three contiguous stereocentres at ring positions 1, 10, and 24.5 Our retrosynthetic 
analysis of the pentacyclic target 1, presented in Scheme 1, led back to the use of (S)-tryptophanol 3, as 
both a source of indole and as the chiral auxiliary in the proposed N-acyliminium cyclization. 
 
Scheme 1. Our retrosynthetic analysis of the manadomanzamine core. 
 
The bifunctional substrate 2 was prepared by an homologation reaction through Wittig 
functionalization of commercially available ketone 4, followed by hydrolysis of the resulting enol ether 
(Scheme 2). Compound 2 is isolated as a mixture of the cis and trans isomers (ca. 1:3 respectively), 
with the trans predominating.2 
 
Scheme 2. (i) CH3OCH2PPh3Cl (2.0 eq.), KOBut (3.0 eq), toluene, RT (64% yield);  
(ii) 2N HCl, 55 oC, THF/H2O (3:1), (99% yield). 
 
Aldehyde 2, a racemate, was subjected to the standard cyclocondensation reaction with (S)-
tryptophanol.4a,d,g,e The use of racemic multi-functional aldehyde substrates in stereoselective 
condensation reactions has been much explored by Bosch and Amat.6 In our hands, the condensation of 
racemic cis/trans-2 with (S)-tryptophanol under Dean-Stark conditions in toluene for 24 hours gave a 
1:1 mixture of two readily separable diastereoisomers 5a,b in 69% overall yield (Scheme 3). 
Presumably the dynamic kinetic resolution that is well known for such substrates under 
cyclocondensation conditions occurs here to give the preferred trans orientation in 2.6 
 
The relative stereochemistry of 5a was determined by n.O.e studies on the isolated compound7 and that 
of isomer 5b by X-ray crystallographic analysis. Whereas diastereoisomer 5a has the correct relative 
and absolute stereochemistry at what will become the C-10 and C-24 positions of the 
manadomanzamine natural products, isomers such as 5b may prove useful in future analogue 
generation studies. The stereochemistry at the noted C-1 position is of no significance at this stage, as 
this corresponding aminal centre will form a planar iminium carbon atom in subsequent reaction steps. 
The stereochemical outcome of the cyclocondensation reaction shown in Scheme 3 can be rationalized 
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by considering the formation of the aminal intermediates from each enantiomer of the aldehyde 
substrate 2, formed en route to the lactam products 5a,b, as highlighted in Scheme 3. 
 
Scheme 3. Cyclocondensation/resolution of rac-aldehyde 2. 
 
The preferred aminal conformations 6a,b allow a favoured trans-decalin-like arrangement of the 
reactive intermediate, with an all-equatorial substituent pattern,6 prior to irreversible lactamization, 
with the H-atom at the aminal carbon centre preferred in an axial arrangement, leading only to minimal 
diaxial interactions in these conformations.  
With individual asymmetric building blocks 5a and 5b in hand, we turned our attention to the proposed 
N-acyliminium cyclization step. These asymmetric building blocks were separately subjected to acid-
induced cyclization reactions promoted by 2M HCl in EtOH at room temperature for 18 hours. Under 
these conditions, substrate 5a underwent clean cyclization in 73% yield to a single diastereoisomer of 
the desired product 8a (Scheme 4). N.O.e experiments subsequently established that the pentacyclic 
product 8a was generated with the correct relative and absolute stereochemistries at ring positions 1, 10 
and 24 as required for the manadomanzamine natural product skeleton.8 
Scheme 4. Access to the manadomanzamine core. 
Such highly diastereoselective cyclization reactions of the indolyl nucleus onto N-acyliminium 
intermediates are now well established,4a,d,e,g,o and the usual rationalization of the observed 
stereochemical induction holds true in this particular case. The stereocontrol arises from a preferred 
conformation, 7a, having minimal A(1,3) strain between the H-atom at the stereogenic centre of the 
tryptophanol moiety and the lactam carbonyl group in the transition state.9 Cyclization of the indolyl 
nucleus thus takes place from a pro-equatorial orientation, leading to a seemingly preferred axial 
2a
O OH
CHO
N OO
H
H
H
H
HN
N OO
H
HN
5a
5b
H
H
H
24
10
1H
H
H
HO2C
OHC
H
S-3
H
HO2C
H
H
N
H O
H
R
lactamization
2b
O OH
CHO
H
H
H
CO2H
CHO
H
S-3
H
CO2H
H
H
N
HO
R
H
lactamization
6a
6b
5a
H
H
7a
2M HCl, EtOH
RT
O
N
H
H
Ar
A(1,3)
R
R = CH2OH
NO
H
H
24
10
1
N
H
HCyclization
OH
8a
 
doi:10.1016/j.tetlet.2007.05.030  
orientation of all three H-substituents at positions C-1, 10 and 24 in compound 8b, matching the 
natural product stereochemistry at these three contiguous asymmetric centres. 
 
Scheme 5. Cyclization of 5b. 
 
In the case of lactam substrate 5b, as outlined in Scheme 5, cyclization proceeded in comparable (75%) 
yield to give a single product diastereoisomer, which was subsequently determined (n.O.e) to have the 
relative stereochemistry shown in structure 8b.10 Again the stereocontrol arises through the preferred 
conformation 7b, minimizing the A(1,3) strain between the H-atom at the stereogenic centre of the 
tryptophanol moiety and the lactam carbonyl group, despite the fact that the transition state must lead 
to a pro-axial attack onto the iminium species by the indolyl nucleus. 
 
In summary, we report the first highly asymmetric synthesis of the pentacyclic core of the 
manadomanzamine alkaloids in only two linear synthetic steps from readily available reagents. Our 
route allows the controlled formation of the correct relative and absolute stereochemistries at the three 
contiguous chiral centres at positions C-1, C-10, and C-24 of the heterocyclic skeleton. Although not 
described in this communication, we have established and reported several routes for removal of the 
hydroxymethyl auxiliary group from similar heterocyclic templates.4d,f Our current work is devoted to 
the development of this synthetic route to allow access to more highly functionalized intermediates and 
thus to a total synthesis of the manadomanzamines and their synthetic analogues, and will be reported 
in due course. 
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